摘要
本文通过动物实验观察较高剂量的β2受体激动剂(喘康速)对迟发型哮喘反应的特征性改变即气道慢性炎症的抑制作用,阐明了治疗哮喘时应用β2受体激动剂的必要性。
This paper explains the necessity of β2-receptor stimulator to treat asthma. The conclusion is drawn from the observation of animal experiments that high dosage of β2 receptor stimulator can inhibit characteristic charges of delaged asthma,namely the chronical airwav inflammation.
出处
《锦州医学院学报》
1996年第3期4-6,共3页
Journal of Jinzhou Medical College